Bristol-Myers Squibb Co. (BMY)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Bristol-Myers Squibb Co. (BMY)
182 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on BMY
- SA Editor Miriam Metzinger(31)
- Mike Huckman(27)
- Mike Havrilla(13)
- SA Editor Eli Hoffmann(12)
- SA Editor Joan Wickham(9)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(679)
- Bill Cara(482)
- David Merkel(471)
- SA Editor Eli Hoffmann(413)
- Andrew Wilkinson(407)
Most commented on authors
- SA Editor Eli Hoffmann(77)
- Mike Stathis (61)
- SA Editor Rachael Granby(54)
- Zacks.com (35)
- SA Editor Joan Wickham(32)
- 9 Possible Pharma Deals for 2009
- India Markets Drop 7.25% as Satyam CEO Resigns
- The 'Reflation' Top Ten Portfolio
- January Gains Delivered
- Will Lilly's Effient Make It Through FDA Review?
- 40 Top Rated Emerging Bio-Pharma Stocks
- Immunogen and Exelixis Defy the Recession
- Study Says Price Controls Bad for Drug Firms and Consumers
- More Biotech Layoffs: Bristol-Myers Squibb, Entremed Feel the Pain
- Bristol Talks the Talk in Mandarin
- Recession-Proof? The Beauty of Big Pharma Is in the Eye of the Beholder
- Strong Dollar's Impact on Pharma vs. Generics
- Thanksgiving Economic Data: Mostly Turkeys
- Stocks Offering 'Healthy' Returns
- Bristol-Myers' Collaboration with Exelixis Is Looking Lucrative
- China Biopharma News Back in the Spotlight
- Navigating the Micro-Cap Biotech Minefield
- Markets Strike Fresh Lows
- Big Pharma Steps Up China Investment
- How Pharma Is Faring in the Financial Crisis
- Parsing the Dismal October Employment Report
- Reality Check on the Big Pharma Rumor Mill
- Wall Street Breakfast: Must-Know News
- Earnings Preview: Bristol Myers Squibb
- Ten Highest Yielding Pharma Stocks
- Even Fatter Yields for Pfizer; M&A Targets in the Sector
- 11 More Potential Buys
- Is It Safe?
- Potential Short Trades on Pending FDA Decisions
- Some Good News in Biotech
- Four Thoughts on the Imclone/Lilly Deal
- Discovery Labs: The Next Biotech Buy?
- Wall Street Breakfast: Must-Know News
- Eli Lilly Sinks In After-Hours Trading On Effient Delay
- Pharmaceuticals: Near Term Movers Based On FDA Decision Dates
- Would a Lilly/Imclone Deal Make Sense?
- Licensing Deal Is Imminent for ArQule
- Wall Street Breakfast: Must-Know News
- Wall Street Breakfast: Must-Know News
- Predictions on Imclone's Suitors
- Lilly Sinks After Hours on Effient Delay
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
4 new today)